Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Sara De Carolis; Francesca Rizzo; Sara Tabacco

doi:10.1016/j.ajog.2017.08.113

Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Sara De Carolis, Francesca Rizzo, Sara Tabacco

University of Rome La Sapienza

Risultato della ricerca: Contributo in rivista › Articolo

2 Citazioni (Scopus)

Abstract

We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.

Lingua originale	Inglese
pagine (da-a)	711-712
Numero di pagine	2
Rivista	American Journal of Obstetrics and Gynecology
Volume	217
Numero di pubblicazione	6
DOI	https://doi.org/10.1016/j.ajog.2017.08.113
Stato di pubblicazione	Pubblicato - 2017
Pubblicato esternamente	Sì

All Science Journal Classification (ASJC) codes

Ostetricia e Ginecologia

Keywords

Antibodies
Antiphospholipid
Antiphospholipid Syndrome
Female
Humans
Hydroxychloroquine
Obstetrics and Gynecology
Pregnancy

Accesso al documento

10.1016/j.ajog.2017.08.113

Altri file e collegamenti

Cita questo

@article{5c9ed1777a644718836ab396aeb1eafd,

title = "Hydroxychloroquine as additional treatment in pregnant patients with refractory APS",

abstract = "We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.",

keywords = "Antibodies, Antiphospholipid, Antiphospholipid Syndrome, Female, Humans, Hydroxychloroquine, Obstetrics and Gynecology, Pregnancy, Antibodies, Antiphospholipid, Antiphospholipid Syndrome, Female, Humans, Hydroxychloroquine, Obstetrics and Gynecology, Pregnancy",

author = "{De Carolis}, Sara and Francesca Rizzo and Sara Tabacco",

year = "2017",

doi = "10.1016/j.ajog.2017.08.113",

language = "English",

volume = "217",

pages = "711--712",

journal = "American Journal of Obstetrics and Gynecology",

issn = "0002-9378",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

AU - De Carolis, Sara

AU - Rizzo, Francesca

AU - Tabacco, Sara

PY - 2017

Y1 - 2017

N2 - We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.

AB - We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.

KW - Antibodies

KW - Antiphospholipid

KW - Antiphospholipid Syndrome

KW - Female

KW - Humans

KW - Hydroxychloroquine

KW - Obstetrics and Gynecology

KW - Pregnancy

KW - Antibodies

KW - Antiphospholipid

KW - Antiphospholipid Syndrome

KW - Female

KW - Humans

KW - Hydroxychloroquine

KW - Obstetrics and Gynecology

KW - Pregnancy

UR - https://publicatt.unicatt.it/handle/10807/112090

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85031281241&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85031281241&origin=inward

U2 - 10.1016/j.ajog.2017.08.113

DO - 10.1016/j.ajog.2017.08.113

M3 - Article

SN - 0002-9378

VL - 217

SP - 711

EP - 712

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

IS - 6

ER -

Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo